Clinical Trial Update: Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients. [Phase 4]

View source ↗

Summary

This Phase 4 update summarizes ophthalmic findings from 10 years of enzyme replacement therapy in Danish Fabry disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Fabry Disease | Phase 4 | Status: COMPLETED